Covered transjugular intrahepatic portosystemic stent-shunt vs large volume paracentesis in patients with cirrhosis: A real-world propensity score-matched study

Table 2 Demographic table showing baseline laboratory data

	Whole cohort					Propensity score-matched cohort
	TIPSS (n = 75)		LVP (n = 75)			TIPSS (n = 40)		LVP (n = 40)
	mean	SD	mean	SD	P value	mean	SD	mean	SD	P value
UKELD	51.51	4.17	54.57	4.84	< 0.001	51.55	4.08	52.45	4.07	0.326
MELD	11.47	3.86	15.93	5.31	< 0.001	12.78	4.492	12.78	3.62	1
INR	1.25	0.19	1.46	0.33	< 0.001	1.25	0.21	1.35	0.23	0.048
Bilirubin (μmol/l)	20.28	16.77	42.13	40.49	< 0.001	22.9	20.027	27.43	21.205	0.33
Creatinine (μmol/l)	96.77	57.13	97.99	78.11	0.914	108.1	73.88	89.75	40.45	0.172
Sodium (mmol/L)	135.40	4.84	134.79	4.67	0.431	135.98	4.092	136.07	4.548	0.918
Platelets (× 109/L)	167.95	73.21	141.16	75.66	0.029	160.43	73.856	154.95	90.098	0.767

UKELD: United Kingdom model for end-stage liver disease; TIPSS: Transjugular intrahepatic portosystemic stent shunt; LVP: Large volume paracentesis; SD: Standard deviation; MELD: Model for end-stage liver disease; INR: International normalized ratio.